Solar
Compare Stocks
4 / 10Stock Comparison
FTCI vs XOM vs CVX vs ARRY
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Solar
FTCI vs XOM vs CVX vs ARRY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Solar | Oil & Gas Integrated | Oil & Gas Integrated | Solar |
| Market Cap | $68M | $620.85B | $364.18B | $1.25B |
| Revenue (TTM) | $96M | $323.90B | $184.43B | $1.21B |
| Net Income (TTM) | $-41M | $28.84B | $12.30B | $-67M |
| Gross Margin | 3.5% | 21.7% | 30.4% | 22.4% |
| Operating Margin | -36.3% | 10.5% | 9.0% | 4.5% |
| Forward P/E | — | 14.3x | 14.7x | 11.8x |
| Total Debt | $34M | $43.54B | $46.74B | $766M |
| Cash & Equiv. | $21M | $10.68B | $6.47B | $244M |
FTCI vs XOM vs CVX vs ARRY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| FTC Solar, Inc. (FTCI) | 100 | 3.2 | -96.8% |
| Exxon Mobil Corpora… (XOM) | 100 | 252.3 | +152.3% |
| Chevron Corporation (CVX) | 100 | 176.0 | +76.0% |
| Array Technologies,… (ARRY) | 100 | 30.4 | -69.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FTCI vs XOM vs CVX vs ARRY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FTCI is the clearest fit if your priority is growth.
- 110.5% revenue growth vs CVX's -4.6%
XOM is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 8.9% margin vs FTCI's -42.1%
- 6.4% ROA vs FTCI's -40.1%
CVX is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 8 yrs, beta -0.05, yield 3.8%
- 135.8% 10Y total return vs XOM's 105.0%
- 3.8% yield, 8-year raise streak, vs XOM's 2.7%, (2 stocks pay no dividend)
ARRY carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 40.2%, EPS growth 62.6%, 3Y rev CAGR -7.8%
- Lower volatility, beta 2.32, current ratio 2.31x
- Beta 2.32, current ratio 2.31x
- Lower P/E (11.8x vs 14.7x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 110.5% revenue growth vs CVX's -4.6% | |
| Value | Lower P/E (11.8x vs 14.7x) | |
| Quality / Margins | 8.9% margin vs FTCI's -42.1% | |
| Stability / Safety | Beta 2.32 vs FTCI's 2.75 | |
| Dividends | 3.8% yield, 8-year raise streak, vs XOM's 2.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +62.7% vs CVX's +39.5% | |
| Efficiency (ROA) | 6.4% ROA vs FTCI's -40.1% |
FTCI vs XOM vs CVX vs ARRY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FTCI vs XOM vs CVX vs ARRY — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
XOM leads in 3 of 6 categories
ARRY leads 1 • FTCI leads 0 • CVX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
XOM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 3368.8x FTCI's $96M. XOM is the more profitable business, keeping 8.9% of every revenue dollar as net income compared to FTCI's -42.1%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $96M | $323.9B | $184.4B | $1.2B |
| EBITDAEarnings before interest/tax | -$34M | $59.9B | $37.1B | $95M |
| Net IncomeAfter-tax profit | -$41M | $28.8B | $12.3B | -$67M |
| Free Cash FlowCash after capex | -$39M | $23.6B | $16.2B | $58M |
| Gross MarginGross profit ÷ Revenue | +3.5% | +21.7% | +30.4% | +22.4% |
| Operating MarginEBIT ÷ Revenue | -36.3% | +10.5% | +9.0% | +4.5% |
| Net MarginNet income ÷ Revenue | -42.1% | +8.9% | +6.7% | -5.6% |
| FCF MarginFCF ÷ Revenue | -40.6% | +7.3% | +8.8% | +4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -17.0% | -1.3% | -5.3% | -26.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -24.1% | -11.0% | -24.5% | -7.0% |
Valuation Metrics
ARRY leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, XOM trades at a 21% valuation discount to CVX's 27.5x P/E. On an enterprise value basis, CVX's 10.9x EV/EBITDA is more attractive than ARRY's 13.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $68M | $620.8B | $364.2B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $81M | $653.7B | $404.5B | $1.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.78x | 21.86x | 27.53x | -11.23x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.31x | 14.68x | 11.83x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 10.91x | 10.89x | 13.50x |
| Price / SalesMarket cap ÷ Revenue | 0.68x | 1.92x | 1.97x | 0.98x |
| Price / BookPrice ÷ Book value/share | — | 2.37x | 1.76x | 4.80x |
| Price / FCFMarket cap ÷ FCF | — | 26.29x | 21.95x | 15.72x |
Profitability & Efficiency
XOM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
XOM delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-21 for ARRY. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARRY's 2.94x. On the Piotroski fundamental quality scale (0–9), CVX scores 5/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +10.7% | +7.2% | -20.6% |
| ROA (TTM)Return on assets | -40.1% | +6.4% | +4.2% | -4.4% |
| ROICReturn on invested capital | — | +8.6% | +6.2% | +9.0% |
| ROCEReturn on capital employed | -86.6% | +8.9% | +6.6% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 5 |
| Debt / EquityFinancial leverage | — | 0.16x | 0.24x | 2.94x |
| Net DebtTotal debt minus cash | $13M | $32.9B | $40.3B | $522M |
| Cash & Equiv.Liquid assets | $21M | $10.7B | $6.5B | $244M |
| Total DebtShort + long-term debt | $34M | $43.5B | $46.7B | $766M |
| Interest CoverageEBIT ÷ Interest expense | -13.63x | 69.44x | 17.22x | -2.42x |
Total Returns (Dividends Reinvested)
XOM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,464 today (with dividends reinvested), compared to $344 for FTCI. Over the past 12 months, ARRY leads with a +62.7% total return vs CVX's +39.5%. The 3-year compound annual growth rate (CAGR) favors XOM at 13.2% vs FTCI's -45.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -65.1% | +20.3% | +18.2% | -15.3% |
| 1-Year ReturnPast 12 months | +43.3% | +43.9% | +39.5% | +62.7% |
| 3-Year ReturnCumulative with dividends | -83.8% | +44.9% | +26.7% | -56.1% |
| 5-Year ReturnCumulative with dividends | -96.6% | +164.6% | +94.0% | -67.7% |
| 10-Year ReturnCumulative with dividends | -97.0% | +105.0% | +135.8% | -77.5% |
| CAGR (3Y)Annualised 3-year return | -45.5% | +13.2% | +8.2% | -24.0% |
Risk & Volatility
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than FTCI's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVX currently trades 85.0% from its 52-week high vs FTCI's 33.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.72x | -0.20x | -0.11x | 2.39x |
| 52-Week HighHighest price in past year | $12.75 | $176.41 | $214.71 | $12.23 |
| 52-Week LowLowest price in past year | $2.90 | $101.19 | $133.77 | $4.92 |
| % of 52W HighCurrent price vs 52-week peak | +33.5% | +83.0% | +85.0% | +67.0% |
| RSI (14)Momentum oscillator 0–100 | 42.2 | 42.4 | 42.1 | 56.4 |
| Avg Volume (50D)Average daily shares traded | 189K | 18.9M | 11.0M | 6.0M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FTCI as "Buy", XOM as "Hold", CVX as "Buy", ARRY as "Buy". Consensus price targets imply 251.3% upside for FTCI (target: $15) vs 6.8% for CVX (target: $195). For income investors, CVX offers the higher dividend yield at 3.76% vs XOM's 2.73%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $15.00 | $161.08 | $194.87 | $9.67 |
| # AnalystsCovering analysts | 12 | 55 | 53 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +2.7% | +3.8% | — |
| Dividend StreakConsecutive years of raises | — | 26 | 8 | 1 |
| Dividend / ShareAnnual DPS | — | $4.00 | $6.87 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.3% | +3.3% | 0.0% |
XOM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARRY leads in 1 (Valuation Metrics). 2 tied.
FTCI vs XOM vs CVX vs ARRY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FTCI or XOM or CVX or ARRY a better buy right now?
For growth investors, FTC Solar, Inc.
(FTCI) is the stronger pick with 110. 5% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 9x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate FTC Solar, Inc. (FTCI) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FTCI or XOM or CVX or ARRY?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
9x versus Chevron Corporation at 27. 5x. On forward P/E, Array Technologies, Inc. is actually cheaper at 11. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FTCI or XOM or CVX or ARRY?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +164.
6%, compared to -96. 6% for FTC Solar, Inc. (FTCI). Over 10 years, the gap is even starker: CVX returned +134. 7% versus FTCI's -96. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FTCI or XOM or CVX or ARRY?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
20β versus FTC Solar, Inc. 's 2. 72β — meaning FTCI is approximately -1490% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 3% for Array Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FTCI or XOM or CVX or ARRY?
By revenue growth (latest reported year), FTC Solar, Inc.
(FTCI) is pulling ahead at 110. 5% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Array Technologies, Inc. grew EPS 62. 6% year-over-year, compared to -43. 3% for FTC Solar, Inc.. Over a 3-year CAGR, XOM leads at -6. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FTCI or XOM or CVX or ARRY?
Exxon Mobil Corporation (XOM) is the more profitable company, earning 8.
9% net margin versus -77. 2% for FTC Solar, Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XOM leads at 10. 5% versus -33. 5% for FTCI. At the gross margin level — before operating expenses — CVX leads at 30. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FTCI or XOM or CVX or ARRY more undervalued right now?
On forward earnings alone, Array Technologies, Inc.
(ARRY) trades at 11. 8x forward P/E versus 14. 7x for Chevron Corporation — 2. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FTCI: 251. 3% to $15. 00.
08Which pays a better dividend — FTCI or XOM or CVX or ARRY?
In this comparison, CVX (3.
8% yield), XOM (2. 7% yield) pay a dividend. FTCI, ARRY do not pay a meaningful dividend and should not be held primarily for income.
09Is FTCI or XOM or CVX or ARRY better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 7% yield, +102. 6% 10Y return). FTC Solar, Inc. (FTCI) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +102. 6%, FTCI: -96. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FTCI and XOM and CVX and ARRY?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FTCI is a small-cap high-growth stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; ARRY is a small-cap high-growth stock. XOM, CVX pay a dividend while FTCI, ARRY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.